August 2024 Price Concessions 1st Update
THIS CONTENT HAS NOW EXPIRED
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/08/2024) announced the following list of price concessions for August 2024:
Drug | Pack size | Price concession |
Amiloride 5mg tablets | 28 | £15.70 |
Amisulpride 200mg tablets | 60 | £28.42 |
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops | 3 | £8.79 |
Cefalexin 500mg capsules | 21 | £2.87 |
Chloramphenicol 0.5% eye drops | 10 | £5.29 |
Cinacalcet 30mg tablets | 28 | £7.75 |
Cyclizine 50mg/1ml solution for injection ampoules | 5 | £4.82 |
Docusate 50mg/5ml oral solution sugar free | 300 | £17.12 |
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free | 60 | £22.46 |
Enalapril 10mg tablets | 28 | £0.94 |
Escitalopram 10mg tablets | 28 | £1.65 |
Escitalopram 20mg tablets | 28 | £1.93 |
Estradiol 10microgram pessaries | 24 | £9.90 |
Etoricoxib 30mg tablets | 28 | £4.21 |
Itraconazole 100mg capsules | 15 | £8.42 |
Labetalol 100mg tablets | 56 | £4.45 |
Lactulose 3.1-3.7g/5ml oral solution | 500 | £4.32 |
Lamotrigine 200mg tablets | 56 | £4.99 |
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops | 2.5 | £4.70 |
Lofepramine 70mg tablets | 56 | £26.95 |
Losartan 12.5mg tablets | 28 | £2.62 |
Mebeverine 200mg modified-release capsules | 60 | £7.41 |
Memantine 20mg tablets | 28 | £1.69 |
Metformin 1g / Sitagliptin 50mg tablets | 56 | £10.65 |
Metformin 1g modified-release tablets | 56 | £3.33 |
Metformin 500mg/5ml oral solution sugar free | 150 | £22.45 |
Methylphenidate 10mg tablets | 30 | £3.42 |
Mometasone 0.1% ointment | 30 | £3.57 |
Mometasone 50micrograms/dose nasal spray | 140 | £8.27 |
Mycophenolate mofetil 500mg tablets | 50 | £5.74 |
Nebivolol 5mg tablets | 28 | £4.21 |
Nefopam 30mg tablets | 90 | £3.68 |
Nicorandil 10mg tablets | 60 | £8.94 |
Nicorandil 20mg tablets | 60 | £15.79 |
Nortriptyline 10mg tablets | 100 | £4.49 |
Olanzapine 2.5mg tablets | 28 | £2.40 |
Olanzapine 5mg tablets | 28 | £4.19 |
Olanzapine 7.5mg tablets | 28 | £1.35 |
Oxycodone 5mg/5ml oral solution sugar free | 250 | £8.48 |
Pregabalin 100mg capsules | 84 | £2.39 |
Pregabalin 150mg capsules | 56 | £2.60 |
Pregabalin 225mg capsules | 56 | £2.31 |
Prochlorperazine 3mg buccal tablets | 50 | £8.69 |
Rizatriptan 10mg tablets | 3 | £8.15 |
Ropinirole 1mg tablets | 84 | £31.89 |
Ropinirole 500microgram tablets | 28 | £13.39 |
Sodium valproate 200mg/5ml oral solution sugar free | 300 | £8.50 |
Sotalol 80mg tablets | 28 | £1.09 |
Tacrolimus 0.1% ointment | 30 | £25.92 |
Trimethoprim 50mg/5ml oral suspension sugar free | 100 | £4.78 |
Zonisamide 100mg capsules | 56 | £27.48 |
For the full list of price concessions granted for August 2024 so far please visit our price concession hub page here.
Please note: We are still in discussion with DHSC on a number other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
In May 2023, DHSC implemented a process to roll over to the following month any agreed prices for concessions requested on or after the 23rd of the month.
Furthermore, from April 2024, a retrospective top-up payment system applies to products granted very low concessionary prices by DHSC when compared to the average purchase prices identified via the Margins survey. Further information on the top-up mechanism can be found here.
Please see our latest funding and reimbursement short video for further information on the recent changes to the price concession